Thyroid Eye Disease: Multidisciplinary Management of Treatment-Associated Hyperglycemia (CME Monograph)
Activity Description and PurposeThis educational activity is intended to help clinicians identify patients with thyroid eye disease (TED) who require intervention for elevated blood glucose levels prior to treatment for TED with the insulin-like growth factor 1 receptor antagonist teprot
Category
  • Ophthalmology
  • Ophthalmology/Neuro-Ophthalmic
Format
  • Monograph
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Thyroid Eye Disease: Multidisciplinary Management of Treatment-Associated Hearing Loss (Online CME Monograph)
This educational activity is intended to help clinicians evaluate real-world data pertaining to hearing dysfunction associated with thyroid eye disease treatment with the insulin-like growth factor 1 receptor antagonist teprotumumab.
Category
  • Ophthalmology
  • Ophthalmology/Neuro-Ophthalmic
Format
  • Monograph
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation